Daniel F Liefwalker Selected Research

9- chloro- 2- (2- furyl)- (1,2,4)triazolo(1,5- c)quinazolin- 5- imine

1/2021

Discovery and Mechanistic Characterization of a Select Modulator of AhR-regulated Transcription (SMAhRT) with Anti-cancer Effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel F Liefwalker Research Topics

Disease

2	Lymphoma (Lymphomas) 08/2021 - 01/2020
2	Neoplasms (Cancer) 08/2021 - 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 08/2021
1	Leukemia 08/2021
1	Breast Neoplasms (Breast Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

1	LipidsIBA 08/2021
1	RNA (Ribonucleic Acid)IBA 08/2021
1	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 08/2021
1	LigandsIBA 01/2021
1	9- chloro- 2- (2- furyl)- (1,2,4)triazolo(1,5- c)quinazolin- 5- imineIBA 01/2021
1	Interferon Type IIBA 01/2020

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020